Background. Mitral annuloplasty may be associated to surgical ventricular restoration (SVR), but risk-to-benefit ratio remains poorly defined. We sought to outline outcome determinants in this high-risk population. Methods. Twenty-six patients with ischaemic cardiomyopathy, prior anteroseptal AMI, NYHA class III-IV, and EF ≤35% who underwent SVR and prosthetic ring mitral annuloplasty were analyzed. Associated cardiac surgical procedures except CABG were excluded. Risk factors for adverse events were identified with logistic and Cox regression. Probabilities of late events were estimated with the Kaplan-Meier method. Primary endpoints were death and hospitalisation for recurrent HF. Results. Preoperative characteristics: age 66 ± 8 years; NYHA class 3.2 ± 0.4; EF 27 ± 5%; WMSI 2.4 ± 0.2; end-systolic volume index (ESVI) 80 ± 25 ml/m2; MR degree 3.3 ± 0.5; EuroSCORE II 15 ± 11. CPB and aortic crossclamp times were 203 ± 68 and 131 ± 28 min. Operative mortality was 11%. No independent predictors of early death emerged. High-dose inotropic support, IABP, and ECMO were necessary in 13, 12, and 1 case. At a mean follow-up of 49 ± 3 months (longest, 112 months), the probability of survival at 1, 3, 5, and 7 years after the operation were 84%, 76%, 72% and 54%, whereas the corresponding probabilities of rehospitalisation for HF were 81%, 52%, 48% and 12%. Baseline ESVI (p=0.03; HR=1.02) and cross-clamp time (p=0.02; HR=1.04) were outlined as independent predictors of late death, but no predictor of recurrent heart failure emerged. Conclusions. Surgical mitral-ventricular restoration can be performed with a near-10% operative risk, and results in over 50% survival at 7 years in advanced ischemic cardiomyopathy. Myocardial viability testing likely represents a crucial additional tool to stratify and optimize patients’ selection with respect to late outcome.

Ventricular restoration with associated mitral annuloplasty: determinants of late outcome / M. Pocar, Z. Wen, D. Passolunghi. - In: GIORNALE ITALIANO DI CARDIOLOGIA. SUPPLEMENTO. - ISSN 1827-8981. - 15:11, suppl. 1(2014 Nov), pp. e51-e51. ((Intervento presentato al 27. convegno Congresso nazionale della Società italiana di chirurgia cardiaca (SICCH) tenutosi a Roma nel 2014 [10.1714/1698.18516].

Ventricular restoration with associated mitral annuloplasty: determinants of late outcome

M. Pocar
Primo
;
D. Passolunghi
2014

Abstract

Background. Mitral annuloplasty may be associated to surgical ventricular restoration (SVR), but risk-to-benefit ratio remains poorly defined. We sought to outline outcome determinants in this high-risk population. Methods. Twenty-six patients with ischaemic cardiomyopathy, prior anteroseptal AMI, NYHA class III-IV, and EF ≤35% who underwent SVR and prosthetic ring mitral annuloplasty were analyzed. Associated cardiac surgical procedures except CABG were excluded. Risk factors for adverse events were identified with logistic and Cox regression. Probabilities of late events were estimated with the Kaplan-Meier method. Primary endpoints were death and hospitalisation for recurrent HF. Results. Preoperative characteristics: age 66 ± 8 years; NYHA class 3.2 ± 0.4; EF 27 ± 5%; WMSI 2.4 ± 0.2; end-systolic volume index (ESVI) 80 ± 25 ml/m2; MR degree 3.3 ± 0.5; EuroSCORE II 15 ± 11. CPB and aortic crossclamp times were 203 ± 68 and 131 ± 28 min. Operative mortality was 11%. No independent predictors of early death emerged. High-dose inotropic support, IABP, and ECMO were necessary in 13, 12, and 1 case. At a mean follow-up of 49 ± 3 months (longest, 112 months), the probability of survival at 1, 3, 5, and 7 years after the operation were 84%, 76%, 72% and 54%, whereas the corresponding probabilities of rehospitalisation for HF were 81%, 52%, 48% and 12%. Baseline ESVI (p=0.03; HR=1.02) and cross-clamp time (p=0.02; HR=1.04) were outlined as independent predictors of late death, but no predictor of recurrent heart failure emerged. Conclusions. Surgical mitral-ventricular restoration can be performed with a near-10% operative risk, and results in over 50% survival at 7 years in advanced ischemic cardiomyopathy. Myocardial viability testing likely represents a crucial additional tool to stratify and optimize patients’ selection with respect to late outcome.
cardiac surgery; heart failure; mitral repair; myocardial infarction
Settore MED/23 - Chirurgia Cardiaca
Settore MED/11 - Malattie dell'Apparato Cardiovascolare
Società Italiana di Chirurgia Cardiaca
Article (author)
File in questo prodotto:
File Dimensione Formato  
01 Comunicazioni.pdf

accesso riservato

Tipologia: Publisher's version/PDF
Dimensione 1.45 MB
Formato Adobe PDF
1.45 MB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/251689
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact